“…It was previously suggested that plasma-derived LDL could be used as a drug delivery system for tumors expressing LDLR since its hydrophobic core has the possibility of incorporating lipophilic drugs (Firestone, 1994, Rensen et al, 2001. Drugs have been either directly loaded onto plasma LDL or the core lipids of LDL were replaced with drugs (Callahan et al, 1999, Ji et al, 2002, Chu et al, 2001, Vitols et al, 1985, Firestone et al, 1984, Dubowchik and Firestone, 1995, Vitols et al, 1990. Plasma LDL, however, is less than ideal as a targeting agent since it is difficult to isolate in large quantities and is variable in composition and size.…”